Modulation of the Surgical Inflammatory Response by Etoricoxib: Peripheral Versus Central.
Phase of Trial: Phase II
Latest Information Update: 08 Apr 2017
At a glance
- Drugs Etoricoxib (Primary)
- Indications Postoperative pain
- Focus Pharmacodynamics; Pharmacokinetics
- 07 Jun 2017 Biomarkers information updated
- 02 May 2012 Actual patient number changed from 12 to 23 as reported by ClinicalTrials.gov.
- 12 Jul 2011 Additional lead trial centre identified as reported by European Clinical Trials Database.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History